Hypophosphorylation of pRB and repression of cyclin D3 and cdc25A during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells

Leukemia Research

Volumn 23, Issue 10, 1999, Pages 901-907

  Shimizu, Takahisa ^a   Oka, Yuichi ^a   Awai, Nao ^a   Takeda, Ken ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

cdc25A; Cyclin D3; Differentiation; GM CSF; Leukemia; pRb; Retinoic acid

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D3; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CDC25 PHOSPHATASE; CELL DIFFERENTIATION; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0032824013     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00106-X     Document Type: Article

References (33)

1. Koeffler H.P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 62:1983;707.
2. Bloch A. Induced cell differentiation in cancer therapy. Cancer Treat. Rep. 68:1984;199.
3. Hozumi M. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv. Cancer Res. 38:1983;121.
4. Hozumi M. Established leukemia cell lines: their role in the understanding and control of leukemia proliferation. CRC Crit. Rev. Oncol. Hematol. 3:1985;235.
5. Breitman T.R., Selonich S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936.
6. Chomienne C., Ballerini P., Balitrand N., Daniel M.T., Fenaux P., Castaigne S., Degos L. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood. 76:1990;1710.
7. Nilsson B. Probable in vitro induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukemia. Br. J. Haematol. 57:1984;365.
8. Huang M., Ye H.-C., Chen S.-R., Chai J.-r, Lu J.-X., Zhoa L., Gu L.-j, Wang Z.-y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567.
9. Castaigne S., Chomienne C., Daniel M.-T., Ballerini P., Berger R., Fenaux P., Degos L. All trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76:1990;1704.
10. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., Lee W.H., Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature. 359:1992;288.
11. Clarke A.R., Maandag E.R., van Roon M., van der Lugt N.M., van der Valk M., Hooper M.L., Berns A., te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature. 359:1992;328.
12. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature. 359:1992;295.
13. Morgenbesser S.D., Williams B.O., Jacks T., DePinho R.A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 72:1994;371.
14. Gu W., Schneider J.W., Condorelli G., Kaushal S., Mahdavi V., Nadai-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:1993;309.
15. Chen P.L., Scully P., Shew J.Y., Wang J.Y., Lee W.H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 58:1989;1193.
16. Furukawa Y., De Caprio J.A., Freedman A., Kanakura Y., Nakamura M., Ernst T.J., Livingston D.M., Griffin J.D. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA. 87:1990;2770.
17. Kiyokawa H., Richon V.M., Rifkind R.A., Marks P.A. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14:1994;7195.
18. Kato J.-y, Sherr C.J. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA. 90:1993;11513.
19. Takeda K., Iwamoto S., Sugimoto H., Takuma T., Kawatani N., Noda M., Masaki A., Morise H., Arimura H., Konno K. Identity of differentiation inducing factor and tumour necrosis factor. Nature. 323:1986;338.
20. Takei M., Takeda K., Konno K. The role interferon- in induction of differentiation of human myeloid leukemia cell lines, ML-1 and HL-60. Biochem. Biophys. Res. Commun. 124:1984;100.
21. Takeda K., Minowada J., Bloch A. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide, or 1-D-arabinofuranosylcytosine. Cancer Res. 42:1982;5152.
22. Oka Y., Takeda K. Retinoic acid combined with GM-CSF induces morphological changes with segmented nuclei in human myeloblastic leukemia ML-1 cells. Anticancer Res. 17:1997;1951.
23. Minowada J. Immunology of leukemia cells. Gunz F., Henderson E. Leukemia. 1983;119 Grune and Stratton, New York.
24. Bachner R.L., Nathan D.G. Quantitative nitroblue tetrazoliumtest in chronic granulomatous disease. New Engl. J. Med. 278:1986;971.
25. Campana D., Coustan-Smith E., Janossy G. Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells. J. Immunol. Methods. 107:1988;79.
26. Yen A., Soong S., Kwon H.J., Yoshida M., Beppu T., Varvayanis S. Enhanced cell differentiation when RB is hypophosphorylated and down-regulated by radicicol, a SRC-kinase inhibitor. Exp. Cell Res. 214:1994;163.
27. Yen A., Varvayanis S. DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation. In vitro cell. Dev. Biol. 31:1995;164.
28. Akiyama T., Toyoshima K. Marked alteration in phosphorylation of the RB protein during differentiation of human promyelocytic HL60 cells. Oncogene. 5:1990;179.
29. Bergh G., Ehinger M., Olofsson T., Baldetorp B., Johnsson E., Brycke H., Lindgren G., Olsson I., Gullberg U. Altered expression of the retinoblastoma tumor-suppressor gene in leukemia cell lines inhibits induction of differentiation but not G1-accumulation. Blood. 89:1997;2938.
30. Bürger C., Wick M., Müller R. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J. Cell. Sci. 107:1994;2047.
31. Galaktionov K., Chen X., Beach D. Cdc25A cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511.
32. Zhu W.-Y., Jones C.S., Kiss A., Matsukuma K., Amin S., De Luca L.M. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp. Cell Res. 234:1997;293.
33. Langenfeld J., Kiyokawa H., Sekula D., Boyle J., Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc. Natl. Acad. Sci. USA. 94:1997;12070.